What are the key features of importance in polycystic ovary syndrome?

Fertility and Sterility

Volumn 80, Issue 2, 2003, Pages 259-261

  Lobo, Rogerio A ^a  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CLOMIFENE; DEXAMETHASONE; FOLLITROPIN; LUTEINIZING HORMONE;

BIOASSAY; DIAGNOSTIC TEST; DISEASE MARKER; HIRSUTISM; HORMONE ACTION; HUMAN; HYPERANDROGENISM; MORBIDITY; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SKIN MANIFESTATION;

EID: 0042065219     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00733-7     Document Type: Note

References (31)

1. Carmina E., Lobo R.A. Polycystic ovary syndrome (PCOS) arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 84:1999;1897.
2. Nestler J.E. Polycystic ovary syndrome a disorder for the generalist . Fertil Steril. 70:1998;811-812.
3. Lobo R.A., Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med. 132:2000;989-993.
4. Lobo R.A. A disorder without identity "HCA," "PCO," "PCOD," "PCOS," "SLS." What are we to call it? Fertil Steril. 63:1995;1158-1160.
5. Azziz, R. Androgen excess is the key element in the polycystic ovary syndrome. Fertil Steril 2003;252-4.
6. Zawadzki J.K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome towards a rational approach . Dunaif A., Givens J.R., Haseltine F., Merriam G.R. Polycystic ovary syndrome. 1992;377-384 Blackwell Scientific Publications, Boston.
7. Chang R.J. Polycystic ovary syndrome diagnostic criteria . Chang R.J., Heinder J.J., Dunaif A. Polycystic ovary syndrome. 2002;361-365 Marcel Dekker, Inc, New York.
8. Polson D.W., Wadsworth J., Adams J., Franks S. Polycystic ovaries a common finding in normal women . Lancet. 1:1988;870-872.
9. Abdel-Gadir A., Khatim M.S., Mowafi R.S., Alnaser H.M., Muharib N.S., Shaw R.W., et al. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlation with basal hormone profiles. Hum Reprod. 7:1992;453-457.
10. Carmina E., Wong L., Chang L., Paulson R.J., Sauer M.V., Stanczyk F.Z., et al. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod. 12:1997;905-909.
11. Carmina E., Lobo R.A. Do hyperandrogenic women with normal menses have PCOS? Fertil Steril. 71:1999;319-322.
12. Carmina E., Lobo R.A. Polycystic ovaries in hirsute women with normal menses. Am J Med. 111:2001;602-606.
13. Wong I.L., Morris R.S., Lobo R.A., Paulson R.J., Sauer M.V. Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation. Hum Reprod. 10:1995;524-528.
14. Chang P., Lindheim S.R., Lowre C., Ferin M., Gonzalez F., Berglund L., et al. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab. 85:2000;995-1000.
15. Hatch R., Rosenfield R.L., Kim M.H., Tredway D. Hirsutism implications, etiology and management . Am J Obstet Gynecol. 140:1981;815-830.
16. Rosner W. An extraordinarily inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab. 86:2001;2903.
17. Carmina E., Ferin M., Lobo R.A. Evidence that insulin and adrenal androgens participate in the regulation of serum leptin levels in women. Fertil Steril. 72:1999;926-931.
18. Lobo R.A., Goebelsmann U., Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab. 57:1983;393-397.
19. Carmina E., Koyama T., Chang L., Stanczyk F.Z., Lobo R.A. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol. 167:1992;1807-1812.
20. Dunaif A. Insulin resistance and the polycystic ovary syndrome mechanisms and implications for pathogenesis . Endocrinol Rev. 18:1997;774-800.
21. Robinson S., Kiddy D., Gelding S.V., Willis D., Niththyananthan R., Bush A., et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf). 39:1993;351-355.
22. Barbieri R.L., Makris A., Randall R.W., Daniels G., Kistner R.W., Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 62:1986;904-910.
23. Nestler J.E., Jakubowicz D.J., de Vargas A.F., Brik C., Quintero N., Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 83:1998;2001-2005.
24. Horton R., Pasupuletti V., Antonipillai I. Androgen induction of 5α-reduction activity may be mediated via insulin like growth factor1. Endocrinology. 1233:1993;447-451.
25. Geffner M.E., Kaplan S.A., Bersch N., Golde D.W., Landaw E.M., Chang R.J. Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil Steril. 45:1986;327-333.
26. Dunaif A., Green G., Futterweit W., Dobrjansky A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 70:1990;699-704.
27. Imani B., Ejkemans M.J., de Jong F.H., Payne N.N., Bouchard P., Guidice L.C., et al. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J Clin Endocrinol Metab. 85:2000;676-682.
28. Lobo R.A., Gysler M., March C.M., Goebelsmann U., Mishell D.R. Jr. Clinical and laboratory predictors of clomiphene response. Fertil Steril. 37:1982;168-174.
29. Lobo R.A., Paul W., March C.M., Granger L., Kletzky O.A. Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol. 60:1982;497-501.
30. Daly D.C., Walters C.A., Soto-Albors C.E., Tohan N., Riddick D.H. A randomized study of dexamethsone in ovulation induction with clomiphene citrate. Fertil Steril. 41:1984;844-848.
31. Lobo R.A., Kletzky O.A., Campeau J.D., diZerega G.S. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil Steril. 39:1983;674-678.